Contract Service Directory

Cambrex





Company Headquarters

1 Meadowlands Plaza
East Rutherford, NJ 07073
United States

Company Description

Cambrex is the small molecule company that provides drug substance, drug product and analytical services across the entire drug lifecycle. Enjoy working with our experts to accelerate your small molecule therapeutics into the market.

With over 35 years’ experience and a growing team of over 2,000 experts servicing our global clients from our sites in North America and Europe, we are tried and trusted in branded and generic markets for API and dosage form development and manufacturing.

Contract Service Directory

    Related Content

    • Breaking News | CRO News | Facilities | Industry News
      CatSci Expands Capabilities with Lab Expansion

      CatSci Expands Capabilities with Lab Expansion

      Continuing strategic growth.
      CatSci 12.11.19

    • Breaking News | Drug Development | Industry News
      Alkermes Acquires Rodin Therapeutics

      Alkermes Acquires Rodin Therapeutics

      Expands Alkermes experience in central nervous system (CNS) diseases and development efforts
      11.19.19

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
      Rentschler Kicks Off Expansion at U.S. Facility

      Rentschler Kicks Off Expansion at U.S. Facility

      New 500 L bioreactor in operation mid-2020 at U.S. site.
      11.11.19


    • Breaking News | Facilities | Industry News | Solid Dosage/Creams/Ointments
      Taiwan-based CDMO Opens U.S. Office

      Taiwan-based CDMO Opens U.S. Office

      Bora Pharmaceuticals to set up shop in Delaware.
      11.01.19

    • APIs | Cytotoxics and High Potency Manufacturing | Facilities
      Flamma Arrives in the U.S.

      Flamma Arrives in the U.S.

      Italian CDMO sets down roots in the U.S. market with purchase of Teva facility.
      Tim Wright, Editor, Contract Pharma 10.15.19

    • Promotions & Moves
      SGS Appoints Global Clinical Ops Director

      SGS Appoints Global Clinical Ops Director

      Steven Thys brings more than 18 years of experience in the pharmaceutical and drug development industry
      09.17.19


    • Cytotoxics and High Potency Manufacturing
      Handling & Assessing HPAPIs

      Handling & Assessing HPAPIs

      As oncology pipelines grow, so too is the demand for highly potent materials, which require careful handling and containment.
      Jason Korbel, Technical Services Manager, Cambrex Charles City 09.16.19

    • Clinical Trials | CRO News | Drug Development
      AES Acquires Bioclinica

      AES Acquires Bioclinica's Clinical Research Site Biz

      Expands global footprint and position in patient access and site conduct
      09.06.19

    • Analytical Services | cGMP Manufacture | Clinical Trial Materials | Drug Development | Industry News
      Permira Funds to Acquire Cambrex in $2.4B Transaction

      Permira Funds to Acquire Cambrex in $2.4B Transaction

      To back Cambrex in its next phase of growth
      08.07.19


    • Promotions & Moves
      MHI Appoints National Accounts Manager

      MHI Appoints National Accounts Manager

      McCracken to help lead sales for emerging player in North American blister machinery market
      07.18.19

    • Promotions & Moves
      Catalent Names SVP, Chief HR Officer

      Catalent Names SVP, Chief HR Officer

      Ricardo Pravda brings more than 25 years of global experience across multiple HR disciplines
      07.18.19